Literature DB >> 22351161

Molecular nature of radiation injury and DNA repair disorders associated with radiosensitivity.

Yuji Masuda1, Kenji Kamiya.   

Abstract

Ionizing radiation (IR), as well as a wide variety of chemicals and reactive oxygen species, can cause insults in DNA integrity. However, IR is distinct from other agents in that produces clustered DNA damage, particularly double-strand DNA breaks (DSBs). The discovery of radiosensitive human diseases has revealed that the molecular mechanisms underlying the biological effects of IR impact cellular responses to and repair of DSBs. One class of diseases, including ataxia-telangiectasia, displays a defect in checkpoint response to DSBs. Another class of diseases exhibits severe combined immunodeficiency and defects in DSB repair. Importantly, radiosensitive human diseases are also associated with increased risks of leukemia/lymphoma. In this review, we summarize the molecular nature of IR-induced DNA damage, and provide an overview of the molecular mechanisms of checkpoint response to and repair of DSBs. Lastly, we discuss the roles of these mechanisms in the development of the immune system and the suppression of lymphoma/leukemia, based on the clinical features and experiments with model mice.

Entities:  

Mesh:

Year:  2012        PMID: 22351161     DOI: 10.1007/s12185-012-1008-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  79 in total

1.  A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation.

Authors:  E K Shin; L E Perryman; K Meek
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

2.  Alternative end joining during switch recombination in patients with ataxia-telangiectasia.

Authors:  Qiang Pan; Corinne Petit-Frére; Aleksi Lähdesmäki; Hanna Gregorek; Krystyna H Chrzanowska; Lennart Hammarström
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

3.  Nibrin functions in Ig class-switch recombination.

Authors:  Sven Kracker; Yvonne Bergmann; Ilja Demuth; Pierre-Olivier Frappart; Gabriele Hildebrand; Rainer Christine; Zhao-Qi Wang; Karl Sperling; Martin Digweed; Andreas Radbruch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

4.  SCID in Jack Russell terriers: a new animal model of DNA-PKcs deficiency.

Authors:  K Meek; L Kienker; C Dallas; W Wang; M J Dark; P J Venta; M L Huie; R Hirschhorn; T Bell
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

5.  Immortalization and characterization of Nijmegen Breakage syndrome fibroblasts.

Authors:  M Kraakman-van der Zwet; W J Overkamp; A A Friedl; B Klein; G W Verhaegh; N G Jaspers; A T Midro; F Eckardt-Schupp; P H Lohman; M Z Zdzienicka
Journal:  Mutat Res       Date:  1999-05-14       Impact factor: 2.433

6.  MDC1 is required for the intra-S-phase DNA damage checkpoint.

Authors:  Michal Goldberg; Manuel Stucki; Jacob Falck; Damien D'Amours; Dinah Rahman; Darryl Pappin; Jiri Bartek; Stephen P Jackson
Journal:  Nature       Date:  2003-02-27       Impact factor: 49.962

7.  MDC1 is a mediator of the mammalian DNA damage checkpoint.

Authors:  Grant S Stewart; Bin Wang; Colin R Bignell; A Malcolm R Taylor; Stephen J Elledge
Journal:  Nature       Date:  2003-02-27       Impact factor: 49.962

8.  MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways.

Authors:  Zhenkun Lou; Katherine Minter-Dykhouse; Xianglin Wu; Junjie Chen
Journal:  Nature       Date:  2003-02-27       Impact factor: 49.962

Review 9.  Splitting the ATM: distinct repair and checkpoint defects in ataxia-telangiectasia.

Authors:  P A Jeggo; A M Carr; A R Lehmann
Journal:  Trends Genet       Date:  1998-08       Impact factor: 11.639

10.  Immunoglobulin class switch recombination is impaired in Atm-deficient mice.

Authors:  Joanne M Lumsden; Thomas McCarty; Lisa K Petiniot; Rhuna Shen; Carrolee Barlow; Thomas A Wynn; Herbert C Morse; Patricia J Gearhart; Anthony Wynshaw-Boris; Edward E Max; Richard J Hodes
Journal:  J Exp Med       Date:  2004-10-25       Impact factor: 14.307

View more
  10 in total

Review 1.  Ubiquitination in disease pathogenesis and treatment.

Authors:  Doris Popovic; Domagoj Vucic; Ivan Dikic
Journal:  Nat Med       Date:  2014-11-06       Impact factor: 53.440

Review 2.  Reversion of the ErbB malignant phenotype and the DNA damage response.

Authors:  E Aaron Runkle; Hongtao Zhang; Zheng Cai; Zhiqiang Zhu; Barry L Karger; Shiaw-Lin Wu; Donald M O'Rourke; Zhaocai Zhou; Qiang Wang; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2012-09-27       Impact factor: 3.362

Review 3.  Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers.

Authors:  Sonja Dragojevic; Jianxiong Ji; Pankaj K Singh; Margaret A Connors; Robert W Mutter; Scott C Lester; Surabhi M Talele; Wenjuan Zhang; Brett L Carlson; Nicholas B Remmes; Sean S Park; William F Elmquist; Sunil Krishnan; Erik J Tryggestad; Jann N Sarkaria
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-08-14       Impact factor: 7.038

4.  Loss of TRPM2 function protects against irradiation-induced salivary gland dysfunction.

Authors:  Xibao Liu; Ana Cotrim; Leyla Teos; Changyu Zheng; William Swaim; James Mitchell; Yasuo Mori; Indu Ambudkar
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways.

Authors:  Qinhua Guo; Pin Guo; Qing Mao; Jin Lan; Yingying Lin; Jiyao Jiang; Yongming Qiu
Journal:  Med Oncol       Date:  2013-02-03       Impact factor: 3.064

6.  Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer.

Authors:  Gissela Borrego-Soto; Rocío Ortiz-López; Augusto Rojas-Martínez
Journal:  Genet Mol Biol       Date:  2015-11-24       Impact factor: 1.771

7.  A pooled mutational analysis identifies ionizing radiation-associated mutational signatures conserved between mouse and human malignancies.

Authors:  Philip R Davidson; Amy L Sherborne; Barry Taylor; Alice O Nakamura; Jean L Nakamura
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

8.  VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance.

Authors:  Weiling Liu; Chuanwang Miao; Shaosen Zhang; Yachen Liu; Xiangjie Niu; Yiyi Xi; Wenjia Guo; Jiahui Chu; Ai Lin; Hongjin Liu; Xinyu Yang; Xinjie Chen; Ce Zhong; Yuling Ma; Yuqian Wang; Shihao Zhu; Shuning Liu; Wen Tan; Dongxin Lin; Chen Wu
Journal:  Signal Transduct Target Ther       Date:  2021-08-30

9.  A novel radioprotective function for the mitochondrial tumor suppressor protein Fus1.

Authors:  E M Yazlovitskaya; R Uzhachenko; P A Voziyan; W G Yarbrough; A V Ivanova
Journal:  Cell Death Dis       Date:  2013-06-20       Impact factor: 8.469

10.  In Silico Investigation of the Biological Implications of Complex DNA Damage with Emphasis in Cancer Radiotherapy through a Systems Biology Approach.

Authors:  Athanasia Pavlopoulou; Seyedehsadaf Asfa; Evangelos Gioukakis; Ifigeneia V Mavragani; Zacharenia Nikitaki; Işıl Takan; Jean-Pierre Pouget; Lynn Harrison; Alexandros G Georgakilas
Journal:  Molecules       Date:  2021-12-15       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.